Skip to main content
. 2017 Dec 19;137(2):295–302. doi: 10.1007/s11060-017-2717-0

Table 2.

ER, PR, and HER2 expression profiles in patients with primary breast cancer and brain metastasis

Brain metastasis Primary breast cancer Total
+
ER status
  10 (47.6%) 1 (4.8%) 11 (52.4%)
 + 1 (4.8%) 9 (42.9%) 10 (47.6%)
PR status
  10 (47.6%) 2 (9.5%) 12 (57.1%)
 + 6 (28.6%) 3 (14.3%) 9 (42.9%)
HER2 status
  10 (47.6%) 3 (14.3%) 13 (61.9%)
 + 2 (9.5%) 6 (28.6%) 8 (38.1%)

ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2